MUC5AC and Pancreatic cysts: In a more recent 2018 diagnostic study, targeted mass spectrometry taken from pancreatic cyst fluid using protein biomarkers from mucin-5AC and prostate stem-cell antigen was able to identify advanced neoplasia with an accuracy of 96%.